The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An ambispective observational study in the safety and efficacy of abiraterone acetate in the French temporary authorizations for use (ATU): Predictive parameters of response.
David Azria
No relevant relationships to disclose
Christophe Massard
No relevant relationships to disclose
Diego Tosi
No relevant relationships to disclose
Nadine Houede
No relevant relationships to disclose
Florence Joly
No relevant relationships to disclose
Gwenaelle Gravis
No relevant relationships to disclose
Remy Delva
No relevant relationships to disclose
Sylvestre Le Moulec
No relevant relationships to disclose
Igor Latorzeff
No relevant relationships to disclose
Jean-Marc Ferrero
No relevant relationships to disclose
Stephane Culine
No relevant relationships to disclose
Sylvain Ladoire
No relevant relationships to disclose
Sophie Tartas
No relevant relationships to disclose
Stephane Oudard
No relevant relationships to disclose
Jean-Michel Pierre Rodier
No relevant relationships to disclose
Brigitte Laguerre
No relevant relationships to disclose
Jerome Alexandre
No relevant relationships to disclose
Delphine Topart
No relevant relationships to disclose
Philippe Beuzeboc
No relevant relationships to disclose